„We must learn to create magical spheres that ... only hit the pathogens.”
Paul Ehrlich 1854-1915
With tailor-made nanocarriers, we will set new standards for the targeted, efficient and low-risk use of active pharmaceutical ingredients and other highly potent substances for medical and life science applications.
NEWS
April 06, 2022
ARTICLE ON PARTICLES: Our cooperation partners at the Institute of Organic Chemistry and Macromolecular Chemistry (IOMC) at the FSU Jena have again succeeded in publishing a high-level paper on the characterization of nanoparticles. The publication on the comparison of methods for the size determination of nanoparticles has recently been accepted by the journal Analytica Chimica Acta. The scientists also used nanoparticles produced by SmartDyeLivery for this purpose. We congratulate on this success!
February 14, 2022
SMARTDYELIVERY IN THE LOCAL PRESS: "We are the freight forwarder" - The article published today in the Thüringer Allgemeine describes our platform technology with vivid metaphors. The current state of research and the upcoming challenges are also brought into public focus.
MILLIONS IN ADDITIONAL FINANCING SECURED: bm-t beteiligungsmanagement thüringen gmbh (bm|t) and a private investor from the existing consortium were convinced by the latest preclinical study results. With the further funding, the first study in humans will be prepared and conducted. We are happy and grateful for the continued trust!
In a first field of application we focus on the targeted transport of active substances in liver cells. We are thus creating a therapeutic option for the treatment of patients with septic cholestasis with the aim of reducing the extremely high mortality rate caused by this complication.
